Published: 4 May 2023

Committees

SUMMARY OF RECOMMENDATIONS FROM THE 121st MEETING OF THE MEDICINES ASSESSMENT ADVISORY COMMITTEE HELD IN WELLINGTON ON THE 24 NOVEMBER 2022.

4. Review of Medicine Evaluations

A term of reference for the Medicine Assessment Advisory Committee (the Committee) is that the Committee should review evaluation reports and provide expert advice to Medsafe and the Minister of Health as to the quality of the risk-benefit assessments that have been completed. 

The Committee reviewed the evaluation reports of 7 applications for the Minister of Health’s consent or provisional consent to the distribution of new medicines. The Committee agreed with the overall risk-benefit assessments and final recommendations for each of the 7 medicine applications.

5.0 General Business

The Committee noted there is currently one vacancy for an oncologist or specialist clinician on the Medicines Assessment Advisory Committee. Medsafe are currently seeking expressions of interest to fulfil this vacancy.